NCAM1 and small cell lung carcinoma: Pathophysiologically, SCLC is a neuroendocrine (NE) malignancy that is characterized by positive for chromogranin A (CgA), Synapsin I (Syn), and neural cell adhesion molecule 1 (NCAM1, also named CD56) based on immunohistochemical analysis3.